Comparative study of apatite formation on CaSiO3 ceramics in simulated body fluids with different carbonate concentrations

被引:90
作者
Iimori, Y
Kameshima, Y
Okada, K [1 ]
Hayashi, S
机构
[1] Tokyo Inst Technol, Dept Met & Ceram Sci, Tokyo 1528552, Japan
[2] Akita Univ, Res Inst Mat & Resources, Akita 0108502, Japan
基金
日本学术振兴会;
关键词
D O I
10.1007/s10856-005-6449-x
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
Apatite formation on CaSiO3 ceramics was investigated using two different simulated body fluids (SBF) proposed by Kokubo (1990) and Tas (2000) and three sample/SBF (S/S) ratios (1.0, 2.5 and 8.3 mg/ml) at 36.5 degreesC for 1-25 days. The CaSiO3 ceramic was prepared by firing coprecipitated gel with Ca/Si = 0.91 at 1400degreesC. The bulk density was 2.14 g/cm(3) and the relative density about 76%. The two SBF solutions contain different concentrations of HCO3- and Cl- ions, the concentrations of which are closer to human blood plasma in the Tas SBF formulation than in the Kokubo formulation. The pH values in the former solution are also more realistic. The CaSiO3 ceramics show apatite formation in SBF (Kokubo) after soaking for only 1 day at all S/S ratios whereas different phases were formed at each S/S ratio in SBF (Tas). The crystalline phases formed were mainly apatite at S/S = 1.0 mg/ml, carbonate-type apatite at 2.5 mg/ml and calcite at 8.3 mg/ml. At higher S/S ratios the increase in the Ca concentration became higher while the P concentration became lower in the reacted SBF. These changes in SBF concentrations and increasing pH occurred at higher S/S ratios, producing more favorable conditions in the SBF for the formation of carbonate bearing phases, finally leading to the formation of calcite instead of apatite in the higher HCO3- ion concentration SBF (Tas). Apatite is, however, formed in the lower HCO3- ion concentration SBF (Kokubo) even though the Ca and P concentrations change in a similar manner to SBF (Tas). (C) 2005 Springer Science + Business Media, Inc.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 16 条
[1]
Aoki H., 1994, Medical applications of hydroxyapatite
[2]
Cho SB, 1996, J BIOMED MATER RES, V32, P375
[3]
In vitro behavior of silica-based xerogels intended as controlled release carriers [J].
Falaize, S ;
Radin, S ;
Ducheyne, P .
JOURNAL OF THE AMERICAN CERAMIC SOCIETY, 1999, 82 (04) :969-976
[4]
Hayashi S., 1991, J CERAM SOC JPN, V12, P1224
[5]
BIOCERAMICS - FROM CONCEPT TO CLINIC [J].
HENCH, LL .
JOURNAL OF THE AMERICAN CERAMIC SOCIETY, 1991, 74 (07) :1487-1510
[6]
Effect of solid/solution ratio on apatite formation from CaSiO3 ceramics in simulated body fluid [J].
Iimori, Y ;
Kameshima, Y ;
Yasumori, A ;
Okada, K .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2004, 15 (11) :1247-1253
[7]
SURFACE-CHEMISTRY OF BIOACTIVE GLASS-CERAMICS [J].
KOKUBO, T .
JOURNAL OF NON-CRYSTALLINE SOLIDS, 1990, 120 (1-3) :138-151
[8]
Okada K., 2004, T MAT RES SOC JPN, V29, P2891
[9]
In vitro calcium phosphate formation on SiO2-Na2O-CaO-P2O5 glass reinforced hydroxyapatite composite: A study by XPS analysis [J].
Santos, JD ;
Jha, LJ ;
Monteiro, FJ .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 1996, 7 (03) :181-185
[10]
Siriphannon P, 2000, J BIOMED MATER RES, V52, P30, DOI 10.1002/1097-4636(200010)52:1<30::AID-JBM5>3.0.CO